Clinical Trial Update: Induction Chemo-Nivo in Unresectable Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy with nivolumab for unresectable stage III non-small cell lung cancer has been terminated. Results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Ralph G Zinner | Conditions: Lung Cancer, Nonsmall Cell, Lung Cancer Stage III | Phase 2 | Status: TERMINATED | Results posted: 2025-04-30